Resumo

LOPEZ RIVERA, Arturo; CARULLA, Diego; CAPO, Adolfo  e  RODRIGUEZ, Martín. Diabetes mellitus tipo 1 de presentación súbita inducida por inhibidores del punto de control inmunitario en el tratamiento de cáncer avanzado. Serie de casos. Rev. Soc. Argent. Diabetes [online]. 2023, vol.57, n.2, pp.105-108. ISSN 0325-5247.

Three patients with advanced cancer, treated with inmune checkpoint inhibitors (ICIs), with no history of diabetes mellitus (DM), were admitted to the Emergency Department with polyuria, polydipsia, and weight loss and a diagnosis of diabetic ketoacidosis without clinical evidence of infection. They were treated with fluids and insulin infusion transitioning to a basal-bolus insulin regimen, which continued after discharge. Autoantibody detection tests for DM were negative and they were diagnosed with DM induced by ICIs, pembrolizumab in two of them, and nivolumab in another. The purpose of this case report is to show the development of DM1 in an acute form in patients treated with PD-1 inhibitors. Based on these cases and the reviewed literature, we seek to identify clinical characteristics and suggest strategies for the proper identification, control, treatment, and follow-up of patients treated with ICIs to minimize the impact of autoimmune dysfunction.

Palavras-chave : diabetes mellitus type 1; diabetic ketoacidosis; immune checkpoint inhibitors.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )